Author

Kerry Reynolds

Institutions: Harvard University, Massachusetts General Hospital, Mass General Brigham

Observed institutions: Harvard University, The University of Melbourne, Massachusetts General Hospital, Mass General Brigham

OpenAlex ID: A5111771959

Precision medicine and personalized breast cancer: combination pertuzumab therapy

2014 · Don Dizon, Kerry Reynolds, et al. · Pharmacogenomics and Personalized Medicine · 20

Reaction of Antibodies to Human Milk Fat Globule(HMFG) with Synthetic Peptides

1989 · Pei X. Xing, Kerry Reynolds, et al. · Springer eBooks · 3

A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib

2026 · Thomas J. Roberts, Catherine B. Meador, et al. · Thyroid · 2

Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinoma

2026 · Eudora Lee, Ralina Karagenova, et al. · medRxiv · 1

Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma

2026 · Eudora Lee, Ralina Karagenova, et al. · JAMA Dermatology

Single-cell RNA sequencing reveals conserved T cell populations across kidney tissue and urine of patients with immune checkpoint inhibitor nephritis 2262974

2026 · Kavita Mistry, Isabela Kernin, et al. · The Journal of Immunology

75814 Evaluating the Safety of Janus Kinase Inhibitors in Management of Severe Immune-related Adverse Events

2026 · Eudora Lee, Lirit Fuksman, et al. · Journal of the American Academy of Dermatology

Immune thrombocytopenia in patients treated with immune checkpoint inhibitors

2025 · Rebecca Leaf, Jodi Mones, et al. · Blood

Works count: 9

Citation count: 26

H-index: 2

I10-index: 1